default author photo

Genoveffa Franchini

Medical University of Bialystok - Centre for Bioinformatics and Data Analysis

Poland

SCHOLARLY PAPERS

2

DOWNLOADS

118

TOTAL CITATIONS

0

Scholarly Papers (2)

1.

Implementation of the User-Friendly Odds Ratio Calculator for Unvaccinated Individuals in a Country with a High COVID-19 Death Toll

Number of pages: 35 Posted: 03 May 2022
Medical University of Bialystok - Centre for Bioinformatics and Data Analysis, Medical University of Bialystok - Centre for Bioinformatics and Data Analysis, Medical University of Bialystok - Centre for Bioinformatics and Data Analysis, Medical University of Bialystok - Clinical Research Centre, Medical University of Silesia - Department of Infectious Diseases in Bytom, Medical University of Silesia - Department of Infectious Diseases in Bytom, Megrez Hospital in Tychy - Department of Infectious Diseases, Medical University of Bialystok - Department of Infectious Diseases and Neuroinfection, Medical University of Bialystok - Department of Infectious Diseases and Neuroinfection, Medical University of Białystok - Department of Infectious Diseases and Hepatology, Medical University of Białystok - Department of Infectious Diseases and Hepatology, Jan Kochanowski University - Department of Infectious Diseases, Wrocław Medical University - Department of Infectious Diseases and Hepatology, Wroclaw Medical University, Poznan University of Medical Sciences - Department of Infectious Diseases, Poznan University of Medical Sciences, Medical University of Bialystok - Clinical Research Centre, Medical University of Lublin - Department of Infectious Diseases and Hepatology, Nicolaus Copernicus University - Department of Infectious Diseases and Hepatology, Medical University of Lodz, Medical University of Łódź - Department of Infectious Diseases and Hepatology, Medical University of Warsaw, Medical University of Warsaw - Department of Adults' Infectious Diseases, Hospital for Infectious Diseases, Hospital for Infectious Diseases, District Hospital in Bielsk Podlaski, Medical University of Lublin - 2nd Department of Anesthesiology and Intensive Care, Medical University of Lublin, Medical University of Lublin, Medical University of Bialystok, Imagene.me SA, Imagene.me SA, Imagene.me SA, Imagene.me SA, Medical University of Bialystok, Medical University of Bialystok - Clinical Research Centre, Medical University of Bialystok - Clinical Research Centre, Medical University of Bialystok - Clinical Research Centre, National Institute of Tuberculosis and Lung Diseases in Warsaw, National Institute of Tuberculosis and Lung Diseases in Warsaw, National Institute of Tuberculosis and Lung Diseases in Warsaw, National Institute of Tuberculosis and Lung Diseases in Warsaw, District Sanitary Inspectorate in Bialystok, Medical University of Bialystok, Medical University of Bialystok - Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok - Department of Regenerative Medicine and Immune Regulation, Medical University of Bialystok, Medical University of Silesia, Humboldt-Universität zu Berlin - Charité, Univeersitätsmedizin Berlin, Medical University of Bialystok - Centre for Bioinformatics and Data Analysis, Medical University of Bialystok - Centre for Bioinformatics and Data Analysis, Institute for Systems Biology, Medical University of Bialystok, Medical University of Bialystok, Medical University of Białystok - Department of Infectious Diseases and Hepatology and Medical University of Bialystok - Department of Regenerative Medicine and Immune Regulation
Downloads 85 (777,583)

Abstract:

Loading...

prediction of the severe course of COVID-19, genomic analysis, whole exome sequencing, odds ratio calculator

2.

Anti-V2 Antibodies Virus Vulnerability Revealed by Envelope V1 Deletion in HIV Vaccine Candidates

Number of pages: 87 Posted: 21 Oct 2020
National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health (NIH) - Section on Intercellular Interactions, Advanced Bioscience Laboratories, Advanced Bioscience Laboratories, New York University (NYU) - NYU Langone Health, New York University (NYU) - NYU Langone Health, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, Government of the United States of America - Henry M. Jackson Foundation for the Advancement of Military Medicine, Duke University - Division of Surgical Sciences, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Structural Biology Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Institutes of Health (NIH) - ImmunoTechnology Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, National Cancer Institute - Animal Models and Retroviral Vaccines Section, Duke University - Department of Surgery, Duke University - Division of Surgical Sciences, Duke University - Medical Center, Duke University - Duke Human Vaccine Institute, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute at Frederick - Human Retrovirus Pathogenesis Section, National Cancer Institute at Frederick - Human Retrovirus Section, National Cancer Institute - Biostatistics and Data Management Section, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory - AIDS and Cancer Virus Program, Frederick National Laboratory for Cancer Research - AIDS and Cancer Virus Program, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, National Institutes of Health (NIH) - Laboratory of Immunoregulation, National Institutes of Health (NIH) - Laboratory of Immunoregulation, Duke University - Division of Surgical Sciences, National Institutes of Health (NIH) - Section on Intercellular Interactions, National Cancer Institute - Immune Biology of Retroviral Infection Section, National Institutes of Health - Vaccine Research Center, National Institutes of Health (NIH) - ImmunoTechnology Section, Walter Reed Army Institute of Research - U.S. Military HIV Research Program, New York University (NYU) - NYU Langone Health and Medical University of Bialystok - Centre for Bioinformatics and Data Analysis
Downloads 33 (1,277,121)

Abstract:

Loading...

HIV, SIV, V1/V2, V1, ALVAC